Abstract

Background: The Swedish oral moist snuff called snus has recently been introduced to the US market. There is a debate whether to introduce snus as a smoking cessation aid. Proponents for this are often affiliated with the tobacco industry and refer to the low percentage of smokers in Sweden as compared to other countries. There are contradictory results regarding the cardiovascular risk of snus use.

Conclusion: With the current scientific knowledge snus should not be recommended for smoking cessation. Snus research should be highlighted to a greater extent to break the myth of snus as a harmless form of tobacco.